ATE127526T1 - Verfahren zur herstellung von natürlichem hiv- glykoprotein 160. - Google Patents

Verfahren zur herstellung von natürlichem hiv- glykoprotein 160.

Info

Publication number
ATE127526T1
ATE127526T1 AT89909487T AT89909487T ATE127526T1 AT E127526 T1 ATE127526 T1 AT E127526T1 AT 89909487 T AT89909487 T AT 89909487T AT 89909487 T AT89909487 T AT 89909487T AT E127526 T1 ATE127526 T1 AT E127526T1
Authority
AT
Austria
Prior art keywords
producing natural
hiv glycoprotein
natural hiv
glycoprotein
iii451
Prior art date
Application number
AT89909487T
Other languages
English (en)
Inventor
Mangalasseril G Sarngadharan
Vaniambadi S Kalyanaraman
Original Assignee
Akzo Nobel Nv
Sarngadharan Mangalasserill G
Vaniambadi S Kalyanaraman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sarngadharan Mangalasserill G, Vaniambadi S Kalyanaraman filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE127526T1 publication Critical patent/ATE127526T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Element Separation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Physical Vapour Deposition (AREA)
AT89909487T 1988-08-16 1989-08-10 Verfahren zur herstellung von natürlichem hiv- glykoprotein 160. ATE127526T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23285988A 1988-08-16 1988-08-16
US07/362,548 US5116740A (en) 1988-08-16 1989-06-07 Method for producing native hiv gp160

Publications (1)

Publication Number Publication Date
ATE127526T1 true ATE127526T1 (de) 1995-09-15

Family

ID=26926401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89909487T ATE127526T1 (de) 1988-08-16 1989-08-10 Verfahren zur herstellung von natürlichem hiv- glykoprotein 160.

Country Status (10)

Country Link
US (1) US5116740A (de)
EP (1) EP0394386B1 (de)
KR (1) KR900702045A (de)
AT (1) ATE127526T1 (de)
AU (1) AU638214B2 (de)
DE (1) DE68924155T2 (de)
DK (1) DK175733B1 (de)
FI (1) FI102684B1 (de)
HK (1) HK1000969A1 (de)
WO (1) WO1990002196A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254457A (en) * 1989-01-11 1993-10-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Monoclonal antibodies and method for identifying different aids-related viruses
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
AU647108B2 (en) * 1990-04-03 1994-03-17 Genentech Inc. Methods and compositions for vaccination against HIV
WO1992006220A1 (en) * 1990-10-05 1992-04-16 President And Fellows Of Harvard College Detection and isolation of ligands
WO1994028929A1 (en) 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
US5736317A (en) * 1995-03-07 1998-04-07 Akzo Nobel N.V. Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
US20020155120A1 (en) * 1996-07-10 2002-10-24 Lowell George H. Protein and peptide vaccines for inducing mucosal immunity
CN1500806B (zh) * 2002-11-14 2010-05-05 上海科华生物工程股份有限公司 一种HIV－1ɡp160膜蛋白及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
WO1990002567A1 (en) * 1988-09-02 1990-03-22 The Ohio State University Research Foundation Virus-derived antigenic composition and its preparation and use

Also Published As

Publication number Publication date
DE68924155D1 (de) 1995-10-12
EP0394386A4 (en) 1991-03-13
AU638214B2 (en) 1993-06-24
FI102684B (fi) 1999-01-29
US5116740A (en) 1992-05-26
DE68924155T2 (de) 1996-04-18
WO1990002196A1 (en) 1990-03-08
FI102684B1 (fi) 1999-01-29
EP0394386A1 (de) 1990-10-31
AU4068789A (en) 1990-03-23
KR900702045A (ko) 1990-12-05
DK175733B1 (da) 2005-02-07
EP0394386B1 (de) 1995-09-06
FI901879A0 (fi) 1990-04-12
DK90090D0 (da) 1990-04-10
HK1000969A1 (en) 1998-05-15
DK90090A (da) 1990-04-10

Similar Documents

Publication Publication Date Title
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
ATE192653T1 (de) Anwendungen von acemannan
AU5510794A (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) gp120 and methods of use
DE68924155D1 (de) Verfahren zur herstellung von natürlichem hiv-glykoprotein 160.
ATE103982T1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
DE3174765D1 (en) High titer production of hepatitis a virus
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
AU2567888A (en) Hiv peptides and methods for detection of hiv
DE59105636D1 (de) Expression von HIV1- und 2- Polypeptiden und deren Verwendung.
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
GR3018918T3 (en) Artificial viral envelopes
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
NL300073I1 (nl) Vaccin.
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
ZA913909B (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i(hiv-1)gpl20 and methods of use
ATE121135T1 (de) Verfahren zur herstellung eines regulationsproteins (nef) von hiv-1 unter verwendung der humanen zellinie th4-7-5.
SE8605535D0 (sv) Cellsystem, dess framstellning och anvendning
ATE92545T1 (de) Verwendung eines goldbades zur herstellung von zahnersatz.
ATE76302T1 (de) Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time